These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9713939)
1. Effect of adjuvants in the isotypes and bactericidal activity of antibodies against the transferrin-binding proteins of Neisseria meningitidis. Gómez JA; Hernández E; Criado MT; Ferreirós CM Vaccine; 1998 Oct; 16(17):1633-9. PubMed ID: 9713939 [TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity of antibodies elicited against the Neisseria meningitidis 37-kDa ferric binding protein (FbpA) with different adjuvants. Gómez JA; Criado MT; Ferreirós CM FEMS Immunol Med Microbiol; 1998 Jan; 20(1):79-86. PubMed ID: 9514578 [TBL] [Abstract][Full Text] [Related]
3. The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains. Ala'Aldeen DA; Borriello SP Vaccine; 1996 Jan; 14(1):49-53. PubMed ID: 8821649 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the human Ig isotype response to individual transferrin binding proteins A and B from Neisseria meningitidis. Johnson AS; Gorringe AR; Fox AJ; Borrow R; Robinson A FEMS Immunol Med Microbiol; 1997 Oct; 19(2):159-67. PubMed ID: 9395061 [TBL] [Abstract][Full Text] [Related]
5. Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine. Rokbi B; Renauld-Mongenie G; Mignon M; Danve B; Poncet D; Chabanel C; Caugant DA; Quentin-Millet MJ Infect Immun; 2000 Sep; 68(9):4938-47. PubMed ID: 10948108 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains. Rokbi B; Mignon M; Maitre-Wilmotte G; Lissolo L; Danve B; Caugant DA; Quentin-Millet MJ Infect Immun; 1997 Jan; 65(1):55-63. PubMed ID: 8975892 [TBL] [Abstract][Full Text] [Related]
7. Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Danve B; Lissolo L; Mignon M; Dumas P; Colombani S; Schryvers AB; Quentin-Millet MJ Vaccine; 1993 Sep; 11(12):1214-20. PubMed ID: 8256502 [TBL] [Abstract][Full Text] [Related]
8. [Influence of adjuvants on the ability of anti-Tbp antibodies to block transferrin binding, iron uptake and growth of Neisseria meningitis]. Ferreirós C; Ferreiro N; Criado MT Enferm Infecc Microbiol Clin; 2002; 20(7):316-20. PubMed ID: 12236996 [TBL] [Abstract][Full Text] [Related]
9. Conservation and antigenic cross-reactivity of the transferrin-binding proteins of Haemophilus influenzae, Actinobacillus pleuropneumoniae and Neisseria meningitidis. Holland J; Parsons TR; Hasan AA; Cook SM; Stevenson P; Griffiths E; Williams P Microbiology (Reading); 1996 Dec; 142 ( Pt 12)():3505-13. PubMed ID: 9004513 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex. Rokbi B; Mignon M; Caugant DA; Quentin-Millet MJ Clin Diagn Lab Immunol; 1997 Sep; 4(5):522-9. PubMed ID: 9302199 [TBL] [Abstract][Full Text] [Related]
11. Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection. West D; Reddin K; Matheson M; Heath R; Funnell S; Hudson M; Robinson A; Gorringe A Infect Immun; 2001 Mar; 69(3):1561-7. PubMed ID: 11179327 [TBL] [Abstract][Full Text] [Related]
12. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae. Humbert MV; Christodoulides M Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of cross-reactive antigens as determinants of cross-bactericidal activity in pathogenic and commensal Neisseria. Sánchez S; Troncoso G; Ferreirós CM; Criado MT Vaccine; 2001 May; 19(25-26):3390-8. PubMed ID: 11348703 [TBL] [Abstract][Full Text] [Related]
14. Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly cross-protective vaccine. Ala'Aldeen DA J Med Microbiol; 1996 Apr; 44(4):237-43. PubMed ID: 8606350 [TBL] [Abstract][Full Text] [Related]
15. Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Ala'Aldeen DA; Stevenson P; Griffiths E; Gorringe AR; Irons LI; Robinson A; Hyde S; Borriello SP Infect Immun; 1994 Jul; 62(7):2984-90. PubMed ID: 8005685 [TBL] [Abstract][Full Text] [Related]
16. In vivo human immune response to transferrin-binding protein 2 and other iron-regulated proteins of Neisseria meningitidis. Ferreirós CM; Ferrón L; Criado MT FEMS Immunol Med Microbiol; 1994 Jan; 8(1):63-8. PubMed ID: 8156052 [TBL] [Abstract][Full Text] [Related]
17. Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential. Gorringe AR; Borrow R; Fox AJ; Robinson A Vaccine; 1995 Sep; 13(13):1207-12. PubMed ID: 8578805 [TBL] [Abstract][Full Text] [Related]
18. Production of Neisseria meningitidis transferrin-binding protein B by recombinant Bordetella pertussis. Coppens I; Alonso S; Antoine R; Jacob-Dubuisson F; Renauld-Mongénie G; Jacobs E; Locht C Infect Immun; 2001 Sep; 69(9):5440-6. PubMed ID: 11500415 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of intranasal and subcutaneous route of immunization in neonatal mice using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria meningitis B. de Oliveira Santos FA; Lincopan N; De Gaspari E Immunobiology; 2018 Dec; 223(12):750-760. PubMed ID: 30055864 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response. Steeghs L; Kuipers B; Hamstra HJ; Kersten G; van Alphen L; van der Ley P Infect Immun; 1999 Oct; 67(10):4988-93. PubMed ID: 10496868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]